Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02579980 · ClinicalTrials.gov registry record · NA
Quantitative Imaging Biomarkers for Sarcoma
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT02579980 is a NA study that has completed, run by Columbia University. The registered enrollment target is 32 participants.
The verdict
NCT02579980, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
Unless a cancer quickly gets smaller with radiation or chemotherapy, the investigators cannot tell if the treatment is working or not. In this research program, two techniques using magnetic resonance imaging (MRI) scanning will be tested in people who have sarcomas, which are rare cancers starting in muscle, tendons, and bones. These particular MRI tests are called dynamic contrast enhanced MRI and diffusion weighted MRI. These MRI scans allow visualization of how sarcomas are different from the normal organs of the body. These MRI tests will tell us the location of sarcoma and its proximity to other structures, as well as correlation of imaging with pathological characteristics after surgery
Interventions
- PROCEDURE Surgery
- PROCEDURE DCE and DWI MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2015-10 |
| Est. Completion | 2017-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02579980
The ClinicalTrials.gov registry entry for NCT02579980 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Surgery is the first listed.
NCT02579980 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02579980 about?
NCT02579980 is a clinical study titled "Quantitative Imaging Biomarkers for Sarcoma". Unless a cancer quickly gets smaller with radiation or chemotherapy, the investigators cannot tell if the treatment is working or not. In this research program, two techniques using magnetic resonance imaging (MRI) scanning will be tested in people who have sarcomas, which are rare cancers starting ...
What is the current status of trial NCT02579980?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2015-10. Estimated completion is 2017-12.
What interventions are being tested in trial NCT02579980?
The interventions under investigation include: Surgery (PROCEDURE), DCE and DWI MRI (PROCEDURE).
Who is sponsoring clinical trial NCT02579980?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.